- About EMBARC
- Patient Resource
- Registry Documents
- EMBARC Registry
The ERS congress has started with a number of contributions on bronchiectasis from researchers from EMBARC and partners. We are delighted to see so many participants at the oral presentation and …Read More
At Congress, the Healthy Lungs for Life campaign will launch its new theme: Take the Active Option. We think this campaign offers a great opportunity to raise awareness of the role of physical …Read More
EMBARC is contributing to a €50 million, Europe-wide, project to develop new drugs that could improve the lives of patients with cystic fibrosis and bronchiectasis.
The iABC (inhaled …Read More
EMBARC will be working hard to promote bronchiectasis at the upcoming ERS congress in Amsterdam. Learn more about EMBARC and get involved in the project at Congress.
Visit the EMBARC stand in the …Read More
A new Cochrane review on the effectiveness of prolonged antibiotics was published today
The review highlighted the paucity of data in bronchiectasis, identifying few trials and only 1157 patients …Read More
The European Respiratory Society Congress in Amsterdam is showcases a wealth of information on all aspects of respiratory health and disease. We are delighted that the first results of the European …Read More
A new study in Thorax makes a further contribution to understanding how frequently bronchiectasis may complicate COPD. This study Suggests that the frequency of bronchiectasis in patients without a …Read More
The 1st World Bronchiectasis Conference is an initiative of EMBARC, the European Bronchiectasis Registry. It is the first conference focusing solely on bronchiectasis. Visit the website at http:// …Read More
Interesting new research from Brazil finds that in asymptomatic elderly never smokers, bronchiectasis may be a "normal" finding in nearly 20% of cases.
19.1% of over-75's undergoing an HRCT scan had …Read More
Congratulations to investigators from the initial pilot sites in the European Bronchiectasis Registry. Recruitment has reached more than 200 patients in less than 2 months of recruitment. …Read More